A faster, cheaper and more reliable test to detect bladder cancer has been developed, US scientists have said. The test, which provides results within an hour, checks for a protein in urine which ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for ...

SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has received 510(k) clearance from the U.S. Food and ...

US-based clinical genetic testing company Natera said that its Signatera test will be utilised in the newly activated ARCHER trial, a Phase III study sponsored by NRG Oncology. The trial focuses on ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for ...

AUSTIN, Texas - Natera, Inc. (NASDAQ:NTRA), a diagnostics company with a market capitalization of $22.37 billion and impressive revenue growth of 44% over the last twelve months, announced Monday that ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Protect your bladder health with these 5 essential health checks. Learn which tests and screenings you need to maintain ...

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...